Elon Musk announced on Tuesday that Neuralink, his neurotechnology startup, had successfully implanted a brain interface in its first human recipient, representing a significant step forward in the company’s mission to create direct communication pathways between the human brain and computers. Musk, who co-founded Neuralink in 2016, expressed excitement about the procedure’s first results.
![](https://axpertmedia.in/wp-content/uploads/2024/01/ElonMuskpic3-Reuters1706580851248-1024x576.jpg)
“The first human underwent an implant from Neuralink yesterday and is recovering well,” Musk said in a post on X, previously Twitter. He said, “Initial results show promising neuron spike detection.”
Read More: Nova AgriTech IPO Allotment Date, GMP, Check Allotment status online
The main objective of Neuralink is to improve human capacities, treat neurological ailments such as ALS or Parkinson’s, and eventually establish a synergistic interaction between people and artificial intelligence.
Last year, Neuralink won clearance from US regulators to begin human testing of their brain implants. The technique relies mostly on a gadget known as the “Link,” which is roughly the size of five stacked pennies. This implant is surgically implanted into the human brain via an invasive process.
According to data provider Pitchbook, Neuralink, situated in California, had a headcount of over 400 workers last year and had raised at least $363 million.
While Elon Musk frequently makes headlines, he is not the only pioneer in the rapidly developing field of brain-machine interface research. Faced with delays, Musk allegedly considered collaborating with implant producer Synchron for a potential investment. Notably, unlike Neuralink’s Link, Synchron’s implant does not need cutting into the skull for placement. In July 2022, the Australian business made a significant milestone by implanting its first device in a patient in the United States.
As Neuralink moves forward in its quest to unlock the potential of brain-computer interfaces, the successful implantation in the first human recipient represents a significant step toward revolutionizing how humans interact with technology and potentially treating debilitating neurological conditions. The world is now anxiously anticipating further advances and the revolutionary impact of Neuralink’s pioneering work.